Cancer Research
Ovarian Cancer Clinical Trials
| Learn more about our current ovarian cancer clinical trials. |
|
Want to Participate?
If you or someone you know may be interested in participating in a clinical trial, contact us at dmccall@phoa.org or (336) 277-8887.
|
||
USO 02044: PHASE III, GEMZAR & CARBOPLATIN FOLLOWED BY TAXOL VERSUS TAXOL & CARBOPLATIN FOLLOWED BY TAXOL
DUMC-03: PHASE III, TAXOTERE & CARBOPLATIN VERSUS SEQUENTIAL TAXOTERE THEN CARBOPLATIN FOR PLATINUM SENSATIVE PATIENTS
TLK 3024: PHASE III, INVESTIGATIONAL TELCYTA AND CARBOPLATIN VERSUS DOXIL 2ND LINE FOR PLATINUM RESISTANT OR REFRACTORY
JJ-OVA301: PHASE III, DOXIL & YONDELIS ( INVESTIGATIONAL) VERSUS DOXIL ALONE, FOR RELASPED PLATINUM RESISTANT OR REFRACTORY
GOG 198 : TAMOXIFEN VERSUS THALIDOMIDE IN BIOCHEMICAL RECURRENCE ONLY,STAGE III / IV












